A Phase 2 Open-Label, Single-Arm, Multicenter Study Of Ruxolitinib Added To Corticosteroids In Pediatric Subjects With Moderate/Severe Chronic Gvhd After Allogeneic Stem Cell Transplantation (Reach5)
Ruxolitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 2 Open-Label, Single-Arm, Multicenter Study Of Ruxolitinib Added To Corticosteroids In Pediatric Subjects With Moderate/Severe Chronic Gvhd After Allogeneic Stem Cell Transplantation (Reach5) ### Output: Ruxolitinib